XYNOMIC PHARMACEUTICALS HOLDINGS, INC. of SHANGHAI, F4, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-15. The offering totals $15.0M. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Thomas Coco Folinsbee | Director | Shanghai, F4 |
| Adam Richard Inglis | Director | Shanghai, F4 |
| Charles Vincent Prizzi | Director | Shanghai, F4 |
| Tingzhi Jason Qian | Director | Shanghai, F4 |
| Jiayuan James Tong | Director | Shanghai, F4 |
| Peidong Richard Wu | Director | Shanghai, F4 |
| Yinglin Mark Xu | Director | Shanghai, F4 |
| Jinwei Coco Kou | Executive Officer | Shanghai, F4 |
| Jiayuan James Tong | Executive Officer | Shanghai, F4 |
| Wentao Jason Wu | Executive Officer | Shanghai, F4 |
| Yinglin Mark Xu | Executive Officer | Shanghai, F4 |